Figure 2.
Figure 2. Complement activation by PF4/heparin correlates with plasma/serum IgM levels. (A) Proteomic analysis of plasmas with a high, intermediate, or low complement response phenotype shows strong correlation with plasma IgM. Graph shows IgM protein intensity determined by proteomic analysis (x-axis) and complement activation response to PF4/heparin, as measured by the antigen-C3c capture ELISA assay (y-axis). (B-D) Serum immunoglobulin levels (IgM, IgG, and IgA) from 29 healthy donors were measured in the clinical laboratory and correlated with an individual’s complement activation response to PF4/heparin, as measured by the antigen-C3c capture ELISA assay. Graphs show correlation of complement activation (y-axis) as a function of immunoglobulin levels (x-axis). Each symbol in the graph represents an individual donor. Complement activation values were normalized to an intermediate donor studied in parallel.

Complement activation by PF4/heparin correlates with plasma/serum IgM levels. (A) Proteomic analysis of plasmas with a high, intermediate, or low complement response phenotype shows strong correlation with plasma IgM. Graph shows IgM protein intensity determined by proteomic analysis (x-axis) and complement activation response to PF4/heparin, as measured by the antigen-C3c capture ELISA assay (y-axis). (B-D) Serum immunoglobulin levels (IgM, IgG, and IgA) from 29 healthy donors were measured in the clinical laboratory and correlated with an individual’s complement activation response to PF4/heparin, as measured by the antigen-C3c capture ELISA assay. Graphs show correlation of complement activation (y-axis) as a function of immunoglobulin levels (x-axis). Each symbol in the graph represents an individual donor. Complement activation values were normalized to an intermediate donor studied in parallel.

Close Modal

or Create an Account

Close Modal
Close Modal